Michael Thomas Heffernan - 20 Dec 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
20 Dec 2021
Net transactions value
$0
Form type
4
Filing time
22 Dec 2021, 20:51:58 UTC
Previous filing
17 Jun 2021
Next filing
29 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award $0 +3,320 $0.000000 3,320 20 Dec 2021 Common Shares 3,320 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 3,320 restricted share units on December 20, 2021, which vested immediately upon grant. These restricted share units will settle on a deferred basis upon the reporting person's retirement from the Board of Directors of the issuer.
F3 Not applicable.

Remarks:

Exhibit List: Exhibit 24: Power of attorney